Drug Interactions between Gengraf and Neoral
This report displays the potential drug interactions for the following 2 drugs:
- Gengraf (cyclosporine)
- Neoral (cyclosporine)
Interactions between your drugs
No interactions were found between Gengraf and Neoral. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Gengraf
A total of 780 drugs are known to interact with Gengraf.
- Gengraf is in the drug class calcineurin inhibitors.
- Gengraf is used to treat the following conditions:
Neoral
A total of 780 drugs are known to interact with Neoral.
- Neoral is in the drug class calcineurin inhibitors.
- Neoral is used to treat the following conditions:
Drug and food interactions
cycloSPORINE food
Applies to: Gengraf (cyclosporine) and Neoral (cyclosporine)
Grapefruit and grapefruit juice can increase the levels of cycloSPORINE in your body and should generally not be consumed during treatment. High blood levels of cycloSPORINE can lead to increased risk of serious side effects on kidney, liver, and nervous system functions. If you regularly consume grapefruits or grapefruit juice, you should be monitored for side effects and/or changes in cycloSPORINE levels. However, do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor. You should also take cycloSPORINE on a consistent schedule with regard to time of day and relation to meals. Let your doctor know if you experience fever, rash, nausea, vomiting, abdominal pain, loss of appetite, dark urine, jaundice (yellowing of the skin or eyes), decreased urination, excessive thirst, swelling, weight gain, dizziness, fatigue, weakness, headache, blurred vision, numbness/burning/tingling in the hand and feet, tremors, or convulsions, as they may be symptoms caused by excessive effects of cycloSPORINE.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Undecapeptide immunosuppressants
Therapeutic duplication
The recommended maximum number of medicines in the 'undecapeptide immunosuppressants' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'undecapeptide immunosuppressants' category:
- Gengraf (cyclosporine)
- Neoral (cyclosporine)
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.